Largest pharmaceutical companies in the United States by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

AbbVie leads the 24 pharmaceutical companies in the United States ranked by total debt, at SAR 253.2B, ahead of Pfizer (SAR 243B) and Merck & Co (SAR 184.9B). Figures as of 20 Nov 2026, 15:25 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AbbVieSAR 253.2B
Median
SAR 8.6B
Combined market value
SAR 14.18T
Countries
1
Not ranked
20no total debt on file

Market values as of .

United States
All sectors
Pharmaceuticals
SAR
Clear filters
Largest pharmaceutical companies in the United States by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health CareSAR 253.2BSAR 1.92TSAR 1,083.51 1.89% up 20% up United States
2PfizerPFE · Health CareSAR 243BSAR 596.8BSAR 104.70 1.36% up 10% up United States
3Merck & CoMRK · Health CareSAR 184.9BSAR 1.26TSAR 511.49 2.68% up 36% up United States
4Johnson & JohnsonJNJ · Health CareSAR 179.8BSAR 2.45TSAR 1,018.55 1.66% up 31% up United States
5Bristol-Myers SquibbBMY · Health CareSAR 169.2BSAR 455BSAR 222.60 1.73% up 26% up United States
6Eli LillyLLY · Health CareSAR 159.4BSAR 4.55TSAR 5,106.91 0.78% up 28% up United States
7ViatrisVTRS · Health CareSAR 54BSAR 85.1BSAR 74.21 0.48% down 90% up United States
8Abbott LaboratoriesABT · Health CareSAR 48.5BSAR 680.4BSAR 392.88 0.85% up 19% down United States
9ZoetisZTS · Health CareSAR 33.9BSAR 124.1BSAR 305.34 0.77% up 34% down United States
10Royalty PharmaRPRX · Health CareSAR 33.6BSAR 147.2BSAR 256.02 0.80% up 74% up United States
11Elanco Animal HealthELAN · Health CareSAR 15.1BSAR 48.9BSAR 97.85 0.76% down 18% up United States
12Amneal PharmaceuticalsAMRX · Health CareSAR 9.6BSAR 27.7BSAR 79.55 0.84% down 79% up United States
13BridgeBio PharmaBBIO · Health CareSAR 7.5BSAR 56.3BSAR 289.25 1.36% down 15% up United States
14Regeneron PharmaceuticalsREGN · Health CareSAR 7.4BSAR 362.6BSAR 3,504.67 1.30% up 22% up United States
15Ionis PharmaceuticalsIONS · Health CareSAR 6.8BSAR 17.2BSAR 103.48 1.36% up 64% down United States
16InsmedINSM · Health CareSAR 2.1BSAR 118.4BSAR 539.75 0.38% down 27% down United States
17Madrigal PharmaceuticalsMDGL · Health CareSAR 1.3BSAR 34.2BSAR 1,470.63 1.17% down 28% down United States
18Legend BiotechLEGN · Health CareSAR 1.2BSAR 11.5BSAR 59.33 1.74% down 43% down United States
19CytokineticsCYTK · Health CareSAR 1.1BSAR 27.5BSAR 197.49 2.32% up 21% down United States
20TG TherapeuticsTGTX · Health CareSAR 921.3MSAR 36.6BSAR 242.23 0.45% down 103% up United States
21Cogent BiosciencesCOGT · Health CareSAR 836MSAR 17.8BSAR 102.22 1.75% down 25% down United States
22Axsome TherapeuticsAXSM · Health CareSAR 704.2MSAR 26.1BSAR 496.20 2.49% down 9% down United States
23Rhythm PharmaceuticalsRYTM · Health CareSAR 405.7MSAR 29.7BSAR 429.03 2.06% down 15% up United States
24Definium TherapeuticsDFTX · Health CareSAR 152.2MSAR 14.9BSAR 108.99 1.42% down 176% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7506 SAR). 20 companies have no total debt on file and are not ranked here.

Questions and answers

Which pharmaceutical companies in the United States rank first by total debt?

AbbVie (SAR 253.2B), Pfizer (SAR 243B) and Merck & Co (SAR 184.9B) are the top three of the 24 pharmaceutical companies in the United States ranked by total debt as of 20 Nov 2026, 15:25 UTC.

How many pharmaceutical companies in the United States are in this ranking?

24 are ranked by total debt. 20 more have no total debt on file and are left out rather than ranked at zero.

What are these pharmaceutical companies in the United States worth together?

The 24 pharmaceutical companies in the United States ranked by total debt have a combined market value of SAR 14.18T as of 20 Nov 2026, 15:25 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.